Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Lantheus Holdings, Inc. Investing Cash Flow

Lantheus Holdings, Inc. (LNTH) reported Investing Cash Flow of $23.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06

  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$2.02M.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $25.99M.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$11.51M.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$319.47M.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$627.17M.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$226.01M, a 3905.61% decline from fiscal 2023.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $5.94M.
  • Lantheus Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$276.55M, a 7608.74% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$2.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$23.96M
10-Q · filed 2026-08-06
$12.45M
derived: sum of 3 quarters · filed 2026-08-06
-$307.01M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$25.99M
10-Q · filed 2026-05-07
$14.48M
derived: sum of 2 quarters · filed 2026-05-07
-$304.99M
derived: sum of 3 quarters · filed 2026-05-07
-$537.46M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$11.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$330.98M
derived: sum of 2 quarters · filed 2026-02-26
-$563.45M
derived: sum of 3 quarters · filed 2026-08-06
-$627.17M
10-K · filed 2026-02-26
2025-09-30-$319.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$551.94M
derived: sum of 2 quarters · filed 2026-08-06
-$615.66M
10-Q · filed 2025-11-06
-$622.26M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$232.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$296.19M
10-Q · filed 2026-08-06
-$302.79M
derived: sum of 3 quarters · filed 2026-08-06
-$370.59M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$63.72M
10-Q · filed 2026-05-07
-$70.32M
derived: sum of 2 quarters · filed 2026-05-07
-$138.12M
derived: sum of 3 quarters · filed 2026-05-07
-$183.20M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$6.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$74.40M
derived: sum of 2 quarters · filed 2026-02-26
-$119.49M
derived: sum of 3 quarters · filed 2026-02-26
-$226.01M
10-K · filed 2026-02-26
2024-09-30-$67.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$112.88M
derived: sum of 2 quarters · filed 2025-11-06
-$219.41M
10-Q · filed 2025-11-06
-$231.48M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$45.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$151.62M
10-Q · filed 2025-08-06
-$163.68M
derived: sum of 3 quarters · filed 2026-02-26
-$80.47M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$106.53M
10-Q · filed 2025-05-07
-$118.60M
derived: sum of 2 quarters · filed 2026-02-26
-$35.38M
derived: sum of 3 quarters · filed 2026-02-26
-$56.08M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$12.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$71.15M
derived: sum of 2 quarters · filed 2026-02-26
$50.45M
derived: sum of 3 quarters · filed 2026-02-26
$5.94M
10-K · filed 2026-02-26
2023-09-30$83.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$62.52M
derived: sum of 2 quarters · filed 2024-11-06
$18.01M
10-Q · filed 2024-11-06
-$246.72M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30-$20.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$65.21M
10-Q · filed 2024-07-31
-$329.93M
derived: sum of 3 quarters · filed 2025-02-26
-$336.02M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31-$44.51M
10-Q · filed 2024-05-02
-$309.24M
derived: sum of 2 quarters · filed 2025-02-26
-$315.33M
derived: sum of 3 quarters · filed 2025-02-26
-$319.67M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31-$264.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$270.81M
derived: sum of 2 quarters · filed 2025-02-26
-$275.16M
derived: sum of 3 quarters · filed 2025-02-26
-$276.55M
10-K · filed 2025-02-26
2022-09-30-$6.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$10.43M
derived: sum of 2 quarters · filed 2023-11-02
-$11.82M
10-Q · filed 2023-11-02
-$16.37M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30-$4.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$5.73M
10-Q · filed 2023-08-03
-$10.28M
derived: sum of 3 quarters · filed 2024-02-22
-$12.70M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$1.39M
10-Q · filed 2023-05-04
-$5.93M
derived: sum of 2 quarters · filed 2024-02-22
-$8.35M
derived: sum of 3 quarters · filed 2024-02-22
-$11.01M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$4.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$6.96M
derived: sum of 2 quarters · filed 2024-02-22
-$9.62M
derived: sum of 3 quarters · filed 2024-02-22
$3.68M
10-K · filed 2024-02-22
2021-09-30-$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$5.08M
derived: sum of 2 quarters · filed 2022-11-03
$8.23M
10-Q · filed 2022-11-03
$4.44M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30-$2.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$10.65M
10-Q · filed 2022-08-04
$6.86M
derived: sum of 3 quarters · filed 2023-02-23
$3.13M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$13.30M
10-Q · filed 2022-04-29
$9.52M
derived: sum of 2 quarters · filed 2023-02-23
$5.78M
derived: sum of 3 quarters · filed 2023-02-23
$11.09M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$3.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
-$7.52M
derived: sum of 2 quarters · filed 2023-02-23
-$2.21M
derived: sum of 3 quarters · filed 2023-02-23
-$4.91M
10-K · filed 2023-02-23
2020-09-30-$3.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.57M
derived: sum of 2 quarters · filed 2021-11-04
-$1.13M
10-Q · filed 2021-11-04
-$5.87M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$5.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$2.61M
10-Q · filed 2021-07-28
-$2.13M
derived: sum of 3 quarters · filed 2022-02-24
-$5.47M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$2.70M
10-Q · filed 2021-05-04
-$7.44M
derived: sum of 2 quarters · filed 2022-02-24
-$10.78M
derived: sum of 3 quarters · filed 2022-02-24
-$14.21M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$4.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$8.08M
derived: sum of 2 quarters · filed 2022-02-24
-$11.51M
derived: sum of 3 quarters · filed 2022-02-24
-$22.06M
10-K · filed 2022-02-24
2019-09-30-$3.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$6.77M
derived: sum of 2 quarters · filed 2020-11-05
-$17.32M
10-Q · filed 2020-11-05
-$24.69M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$3.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
-$13.98M
10-Q · filed 2020-07-31
-$21.35M
derived: sum of 3 quarters · filed 2021-02-25
-$26.36M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$10.55M
10-Q · filed 2020-04-30
-$17.92M
derived: sum of 2 quarters · filed 2021-02-25
-$22.92M
derived: sum of 3 quarters · filed 2021-02-25
-$28.55M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$7.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$12.37M
derived: sum of 2 quarters · filed 2021-02-25
-$18.00M
derived: sum of 3 quarters · filed 2021-02-25
-$19.13M
10-K · filed 2021-02-25
2018-09-30-$5.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
-$10.63M
derived: sum of 2 quarters · filed 2019-10-31
-$11.77M
10-Q · filed 2019-10-31
-$17.72M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$5.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
-$6.76M
10-Q · filed 2019-07-25
-$12.71M
derived: sum of 3 quarters · filed 2020-02-25
-$16.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$1.14M
10-Q · filed 2019-04-30
-$7.09M
derived: sum of 2 quarters · filed 2020-02-25
-$10.38M
derived: sum of 3 quarters · filed 2020-02-25
-$12.88M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$5.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$9.24M
derived: sum of 2 quarters · filed 2020-02-25
-$11.74M
derived: sum of 3 quarters · filed 2020-02-25
-$16.31M
10-K · filed 2020-02-25
2017-09-30-$3.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
-$5.79M
derived: sum of 2 quarters · filed 2018-10-30
-$10.36M
10-Q · filed 2018-10-30
-$12.71M
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30-$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
-$7.07M
10-Q · filed 2018-08-01
-$9.43M
derived: sum of 3 quarters · filed 2019-02-20
2017-03-31-$4.56M
10-Q · filed 2018-05-02
-$6.92M
derived: sum of 2 quarters · filed 2019-02-20
2016-12-31-$2.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
$3.28M
10-K · filed 2019-02-20
2016-09-30$5.64M
10-Q · filed 2017-11-02
2015-12-31-$13.15M
10-K · filed 2018-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B